Stay updated on ARGX-113 Safety & Efficacy in Pemphigus Clinical Trial
Sign up to get notified when there's something new on the ARGX-113 Safety & Efficacy in Pemphigus Clinical Trial page.

Latest updates to the ARGX-113 Safety & Efficacy in Pemphigus Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedFooter now shows Revision: v3.3.3 and the HHS Vulnerability Disclosure link has been removed, replacing the prior reference to Revision: v3.3.2.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedMinor editorial updates were made to the Publications section, replacing the PubMed note and updating the revision from v3.2.0 to v3.3.2; no substantive study details are affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check54 days agoChange DetectedThe government funding/operating status notice was removed. The core study details and page content remain unchanged.SummaryDifference0.4%

- Check69 days agoChange DetectedThe screenshots show no changes to essential study details. Any differences are minor visual layout adjustments rather than updates to core content.SummaryDifference0.4%

- Check97 days agoChange DetectedMajor update: new operating-status notice and a v3.2.0 version release, replacing the old v3.1.0.SummaryDifference4%

- Check104 days agoChange DetectedThe page has been updated to Revision: v3.1.0, replacing the previous v3.0.2.SummaryDifference0.1%

Stay in the know with updates to ARGX-113 Safety & Efficacy in Pemphigus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARGX-113 Safety & Efficacy in Pemphigus Clinical Trial page.